Company Analysis

OptimizeRx Corporation (OPRX)

Nasdaq: OPRX · Services-Business Services, NEC · Waltham, MA · filing with the SEC since 2008
Grade5.0
◀ Past 5.6● Present 4.9▶ Future 4.8

Filings

408 filings since 2017 beside 380 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.

Filings a yearinsider forms included
84981386053798041
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 11 times in the last 36 months, the newest Aug 12, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Mar 30, 2026.SEC letters: 2 in the last 36 months, the newest Apr 3, 2025.A late-filing notice, Form NT 10-Q, filed Aug 15, 2024.A late-filing notice, Form NT 10-K, filed Mar 28, 2024.
Insider forms 380

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 21, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 20, 2026 S-8 Employee stock plan registration
Aug 14, 2026 SCHEDULE 13G Large holder notice
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 12, 2026 8-K items 2.02, 5.02, 7.01, 9.01 Results released; Officer or director change; Investor disclosure (Regulation FD) · Current report Aug 7, 2026
Jul 29, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 22, 2026 SCHEDULE 13G Large holder notice
Jun 12, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Jun 9, 2026
Jun 5, 2026 8-K item 5.02 Officer or director change · Current report Jun 1, 2026
Jun 1, 2026 DEFA14A Extra proxy material
May 13, 2026 10-Q Quarterly report Mar 31, 2026
May 12, 2026 8-K items 1.01, 1.02, 2.02, 2.03, 9.01 Major agreement signed; Major agreement ended; Results released; New debt or obligation taken on · Current report
Apr 30, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 30, 2026 DEF 14A Proxy statement Jun 9, 2026
Apr 9, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Apr 3, 2026
Mar 30, 2026 8-K items 4.01, 9.01 Auditor change · Current report Mar 24, 2026
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 12, 2026 10-K Annual report Dec 31, 2025
Mar 5, 2026 8-K items 1.01, 2.02, 8.01, 9.01 Major agreement signed; Results released; Other event · Current report
Nov 7, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 31, 2025 SCHEDULE 13G Large holder notice
Aug 19, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Aug 15, 2025
Aug 8, 2025 10-Q Quarterly report Jun 30, 2025
Aug 7, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 16, 2025 SCHEDULE 13G/A Large holder update, amended
Jun 24, 2025 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Jun 20, 2025
Jun 16, 2025 8-K item 5.07 Shareholder vote · Current report Jun 11, 2025
May 13, 2025 10-Q Quarterly report Mar 31, 2025
May 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Apr 30, 2025 ARS Annual report to shareholders Dec 31, 2024
Apr 30, 2025 DEF 14A Proxy statement Jun 11, 2025
Apr 30, 2025 SCHEDULE 13G/A Large holder update, amended
Apr 21, 2025 SCHEDULE 13D/A Activist holder update, amended
Apr 18, 2025 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Apr 7, 2025 EFFECT Registration effective
Apr 3, 2025 CORRESP Reply to the SEC
Apr 2, 2025 UPLOAD SEC comment letter
Mar 28, 2025 S-3 Shelf registration
Mar 20, 2025 10-K Annual report Dec 31, 2024
40 of 408 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton OPRX · research, not advice